TAS-118

· Taiho Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAS-118, covering 2021-12-20 to 2021-12-20. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer [Phase 3]

See pricing